Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarvari V. Yellapragada"'
Autor:
Charles B. Nguyen, Monica Li, Gordana Verstovsek, Urmi Sen, Christi Swierenga, Quillan Huang, Gustavo Rivero, Sarvari V. Yellapragada
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3129-3132 (2020)
Abstract The addition of radiation therapy to chemotherapy and impact on outcomes in primary bone lymphoma is not clear. Nonetheless, tumor location must be considered as radiation to marrow‐rich bone areas can lead to myelosuppression and myelotox
Externí odkaz:
https://doaj.org/article/5ffba2774574401eae074b237760f096
Autor:
Laure Maneix, Polina Iakova, Shannon E. Moree, Joanne I. Hsu, Ragini M. Mistry, Fabio Stossi, Premal Lulla, Zheng Sun, Ergun Sahin, Sarvari V. Yellapragada, André Catic
Publikováno v:
Cancer Research Communications. 2:1693-1710
Proteasome inhibitors have become the standard of care for multiple myeloma. Blocking protein degradation particularly perturbs the homeostasis of short-lived polypeptides such as transcription factors and epigenetic regulators. To determine how prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8954a9b43884b6d251b61e9b1629b73
https://doi.org/10.1158/2767-9764.crc-22-0255
https://doi.org/10.1158/2767-9764.crc-22-0255
Autor:
André Catic, Sarvari V. Yellapragada, Ergun Sahin, Zheng Sun, Premal Lulla, Fabio Stossi, Ragini M. Mistry, Joanne I. Hsu, Shannon E. Moree, Polina Iakova, Laure Maneix
HDAC3 mediates repression of the H3K27ac mark at super-enhancers of genes relevant for MM biology following proteasome inhibition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451d629b9c33b63515fd4598b4bdf41d
https://doi.org/10.1158/2767-9764.22546586.v1
https://doi.org/10.1158/2767-9764.22546586.v1
Autor:
André Catic, Sarvari V. Yellapragada, Ergun Sahin, Zheng Sun, Premal Lulla, Fabio Stossi, Ragini M. Mistry, Joanne I. Hsu, Shannon E. Moree, Polina Iakova, Laure Maneix
RNA-seq data for Volcano plot Fig. 1A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d0d68a51f86c6679492a09e8383d6e
https://doi.org/10.1158/2767-9764.22546577
https://doi.org/10.1158/2767-9764.22546577
Autor:
André Catic, Sarvari V. Yellapragada, Ergun Sahin, Zheng Sun, Premal Lulla, Fabio Stossi, Ragini M. Mistry, Joanne I. Hsu, Shannon E. Moree, Polina Iakova, Laure Maneix
Proteasome inhibitors have become the standard of care for multiple myeloma. Blocking protein degradation particularly perturbs the homeostasis of short-lived polypeptides such as transcription factors and epigenetic regulators. To determine how prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9bc928b7f1474e0df62f90018bdda8
https://doi.org/10.1158/2767-9764.c.6551216.v1
https://doi.org/10.1158/2767-9764.c.6551216.v1
Autor:
Laure Maneix, Sarvari V. Yellapragada, Andre Catic, Premal Lulla, Luke Fletcher, Polina Iakova, Shannon Moree
Publikováno v:
Cancer Research. 78:1847-1847
Transcription factors (TFs) are generally short-lived proteins that undergo active turnover. The dynamic interaction of TFs and co-regulators with promoters and enhancers allows cells to continuously adjust gene expression. Whereas the composition an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a6dd5da8f89f32b4447d900c90075a
https://doi.org/10.1158/1538-7445.am2018-1847
https://doi.org/10.1158/1538-7445.am2018-1847